SEC Filings
Oasis Fund Has Bought Nam Tai Property Shares On 31 Trade Dates, Lifting Stake To 21.9%
Oasis Management and its affiliates hold 13,338,297 shares after open-market buying at or near $4.30 a share.
SEC Filings
Oasis Management and its affiliates hold 13,338,297 shares after open-market buying at or near $4.30 a share.
SEC Filings
The drug developer says none of the contingent payments to its China-based licensor were considered probable as of September 30, 2026.
SEC Filings
The cruise operator can issue notes maturing in up to 180 days, with its revolving credit facility planned as the backstop.
SEC Filings
TeraWulf also signed a definitive Fluor construction deal, with phased service beginning in late 2027.
SEC Filings
The narcolepsy drugmaker held its 2026 WAKIX guidance at $1.0 billion to $1.04 billion and posted early safety data for BP-205.
SEC Filings
Nabeel Al-Amudi and Toni Townes-Whitley join the Audit & Risk and Compensation committees on December 1, 2026.
SEC Filings
Reported operating profit fell 9% on DKK 8.7 billion of non-cash impairments, and CFO Karsten Munk Knudsen will leave at the end of December.
SEC Filings
The 910-megawatt deal carries about $1.8 billion in average annual rent, and Riot says it does not currently anticipate issuing equity to fund it.
SEC Filings
The biotech sold stock, notes and private shares on October 30, and now says its cash lasts through the end of 2029.
SEC Filings
The gene therapy maker's quarterly report says the 48-month readout was left out of its FDA filing, now under priority review with a May 1, 2027 target date.
SEC Filings
The fintech curtailed buybacks and paused tuck-in deals to cut debt, which stood at $20.8 billion on September 30.
SEC Filings
The biotech's cash fell to $498.5 million as an undrawn $50.0 million tranche folded into a lender-approval tranche now up to $250.0 million.